BYAH.US Park Ha Biological Technology Co., Ltd.
- Market cap
- USD 28.3M
- P/E
- -
- P/B
- 0.22x
- ROE
- -51.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Apr 2026.
Is BYAH.US undervalued?
Graham numberThe Graham number of Park Ha Biological Technology Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Park Ha Biological Technology Co., Ltd. fundamental analysis
No fundamental analysis for Park Ha Biological Technology Co., Ltd. yet.
Park Ha Biological Technology Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The c…
Full company profilePark Ha Biological Technology Co., Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Apr 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Park Ha Biological Technology Co., Ltd. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 931K | 1.92M | 2.46M | 2.38M | 2.52M | 3.77M |
| Gross Profit | 620K | 1.41M | 2.15M | 2.19M | 2.38M | 3.45M |
| Operating Income | -501K | 197K | 1.18M | 794K | -24.1M | -2.89M |
| EBITDA | -445K | 221K | 1.20M | 816K | -24.0M | -2.60M |
| Net Income | -485K | 191K | 852K | 479K | -24.4M | -2.75M |
| EPS | -7.40 | 2.92 | 13 | 7.31 | -331 | -4.47 |
| Balance Sheet | ||||||
| Total Assets | 594K | 2.52M | 2.26M | 3.08M | 5.95M | 7.46M |
| Total Liabilities | 1.17M | 2.37M | 1.25M | 1.58M | 1.96M | 2.07M |
| Shareholders' Equity | -578K | 150K | 1.01M | 1.51M | 3.99M | 5.39M |
| Cash & Short-term Investments | 72.7K | 575K | 1.03M | 547K | 3.79M | 5.66M |
| Total Debt | 35.2K | 26.2K | 31.5K | 70.3K | 180K | 186K |
| Cash Flow | ||||||
| Operating Cash Flow | -498K | 1.44M | 127K | 960K | 85.9K | -341K |
| Capital Expenditure | 12.9K | 11.9K | 22.7K | 85.6K | 88.8K | 675K |
| Free Cash Flow | -511K | 1.43M | 104K | 875K | -2.97K | -1.02M |
| Ratios | ||||||
| ROE | - | 127.3% | 84.2% | 31.8% | -609.9% | -51.1% |
| ROA | -81.6% | 7.6% | 37.6% | 15.5% | -409.3% | -36.9% |
| Net Profit Margin | -52.1% | 10.0% | 34.6% | 20.1% | -965.0% | -73.0% |
| Debt to Equity | - | 0.17x | 0.03x | 0.05x | 0.05x | 0.03x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Park Ha Biological Technology Co., Ltd. dividends
Park Ha Biological Technology Co., Ltd. has not paid dividends in the last 5 fiscal years.
Last stock split: 1:8 on Aug 6, 2026.
Who owns Park Ha Biological Technology Co., Ltd.
- Insiders 30.11%
- Institutions 0.22%
- Public & others 69.67%
- Shares outstanding 19.5M
- Free float 539K
Top funds holding BYAH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 338.00 | 0.01% | 0.00% | May 2026 |
Top institutions holding BYAH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Morgan Stanley - Brokerage Accounts | 25.0K | 0.13% | +156,250.00% | Jun 2026 |
| Caitong International Asset Management Co., Limited. | 3.00 | 0.00% | 0.00% | Jun 2026 |
| UBS Group AG | 0.00 | 0.00% | -100.00% | Jun 2026 |
Park Ha Biological Technology Co., Ltd. company profile
- Company name
- Park Ha Biological Technology Co., Ltd.
- Ticker
- BYAH.US
- ISIN
- KYG6925R1103
- Exchange
- USA Stocks
- Listed since
- Dec 27, 2024
- Sector
- Consumer Defensive
- Industry
- Specialty Retail
- Employees
- 41
- Fiscal year end
- October
- Address
- Building C, Wuxi, China, 214100
- Phone
- 86 40 0012 7562
- Website
- parkha.cn
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company has a strategic partnership with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach. Park Ha Biological Technology Co., Ltd. has strategic partnership with Cloud Factory Technology Holdings Limited to build ai-driven ecosystem for the beauty industry. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
Park Ha Biological Technology Co., Ltd. management
3- Ms. Xiaoqiu ZhangCEO & Chairman of the Board · born 1981
- Ms. Xiaoyan ZhuChief Financial Officer · born 1978
- Ms. Xinyu LiCTO & Product Manager · born 1986